What does ZBIO invest in?

ProShares UltraPro Short Nasdaq Biotechnology is a equity fund issued by ProShares. ZBIO focuses on health care investments and follows the NASDAQ Biotechnology Index. The fund's investments total to approximately $2.85 million assets under management.

What is the management fee for ProShares UltraPro Short Nasdaq Biotechnology?

ProShares UltraPro Short Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 1.02%. However, ZBIO has a fee waiver of -0.82% to reimburse the expenses. The net expense ratio for ZBIO is 0.95%.

What other stocks do shareholders of ProShares UltraPro Short Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Short Nasdaq Biotechnology investors own include ProShares UltraPro Short QQQ (SQQQ) , ProShares UltraPro QQQ (TQQQ) , Immunomedics (IMMU) , Direxion Daily S&P Biotech Bear 3x Shares (LABD) , Direxion Daily S&P Biotech Bull 3x Shares (LABU) , Direxion Daily Semiconductors Bull 3x Shares (SOXL) , Direxion Daily Small Cap Bull 3X Shares (TNA) , Direxion Daily Small Cap Bear 3X Shares (TZA) , Verizon Communications (VZ) and Eaton Vance Tax-Managed Buy-Write Opportunities Fund (ETV) .

NASDAQ:ZBIO

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) Price, Holdings, & News

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ZBIO Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.09
▼
$10.09
50-Day Range: $10.02
▼
$10.09
52-Week Range: $8.28
▼
$18.64

Volume: N/A
Average Volume: 32,378 shs
Market Capitalization: $2.52 million

Assets Under Management: $2.85 million
Dividend Yield: 0.30%
Net Expense Ratio: 0.95%

Stock Analysis

Get ProShares UltraPro Short Nasdaq Biotechnology alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ZBIO ETF News Headlines

February 25, 2023 | benzinga.com

Bullfrog AI Hldgs Stock (NASDAQ:BFRG), Quotes and News Summary

February 16, 2023 | morningstar.com

ProFunds Short NASDAQ-100 Svc

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 17, 2022 | wsj.com

Nasdaq Biotechnology Index NBI

August 23, 2022 | ca.finance.yahoo.com

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)

See More Headlines

Receive ZBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraPro Short Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: ProShares
Fund Name: ProShares UltraPro Short Nasdaq Biotechnology
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:ZBIO
Inception Date: 6/22/2015
Fund Manager: Michael Neches, Tarak Dave
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: NASDAQ Biotechnology Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 0

Fund Statistics

Assets Under Management: $2.85 million
Average Daily Volume: $25,501.70
Discount/Premium: 0.00%

Administrator, Advisor and Custodian

Administrator: J.P. Morgan Investor Services Co.
Advisor: ProShare Advisors LLC
Custodian: JPMorgan Chase Bank, N.A.
Distributor: SEI Investments Distribution Co.
Transfer Agent: JPMorgan Chase Bank, N.A.
Trustee: N/A
Lead Market Maker: Virtu Financial

Miscellaneous

Outstanding Shares: 250,000
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ProShares UltraPro Short Nasdaq Biotechnology Expenses

Type	ZBIO	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.75%	0.56%	0.54%	0.48%	0.51%
Other Expenses	1.02%	0.40%	0.54%	0.34%	0.58%
Total Expense	1.77%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	-0.82%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.95%	0.60%	0.60%	0.54%	0.58%